WASHINGTON (Reuters) - AIDS vaccine researchers should move to smaller, more focused trials and dump any vaccines that do not show strong promise, the International AIDS Vaccine Initiative said ...
... Moving forward
The results of the Phase I vaccine trial of TBC-M4 suggest that further ... forward with additional testing of this MVA-based AIDS vaccine candidate.
Simultaneously, IAVI has undertaken ...
WASHINGTON (Reuters) - A new AIDS vaccine research center dedicated to solving one of the stickiest problems holding back development of such a vaccine will open in California, researchers announced ...
WASHINGTON (Reuters) - A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory ...
One year after a puzzling setback in the hunt for an AIDS vaccine, researchers say their defeats have forced them to look for entirely new ways of creating a defence against the disease.
New York City lab opens amid challenges for AIDS vaccines
MIT is joining a bold new initiative to develop an AIDS vaccine. Founded through a 10-year, $100 million grant from the Phillip T. and Susan M. Ragon Institute Foundation, the ...
LONDON, Ontario, July 1 (UPI) -- Scientists said an HIV/AIDS vaccine developed at Canada's University of Western Ontario is ready for the first phase of human trials.
CAPE TOWN, South Africa (AP) -- South Africa is launching clinical trials of the first AIDS vaccines created by a developing country, a feat by scientists who forged ahead ...
... , believe conventional vaccine strategies should not be the only avenue explored in the development of an effective AIDS vaccine. Based on studying simian immunodeficiency viruses (SIVs) in African ...
A new AIDS vaccine tested in Thailand has protected a significant minority against infection, the first time any vaccine against the disease has even partly succeeded in a clinical trial.
Data released last month showing an AIDS vaccine’s promise are weaker than believed, reports find.
Fresh results from the world's first successful test of an experimental AIDS vaccine confirm that it is only marginally effective and suggest that its protection against HIV infection may wane over ...
... chance, a report in the New England Journal of Medicine
says.
A secondary analysis of data from the Thai AIDS vaccine trial --
announced last month to much acclaim -- suggests that the vaccine
might ...
PARIS (Reuters) - Merck and Co's failed AIDS vaccine may not have worked, but it probably did not raise the risk of infection either, doctors said on Tuesday.
